Auditor21 May 2026, 09:11 pm
Aurobindo Pharma Appoints RPR & Associates as Auditor
AI Summary
Aurobindo Pharma Ltd has appointed RPR & Associates as its Secretarial Auditor for a five-year term commencing from FY 2026-27, subject to shareholder approval at the upcoming Annual General Meeting. This follows the resignation of MRR & Associates, effective May 22, 2026, due to the health issues of its sole proprietor. The board meeting, held on May 21, 2026, which approved the appointment, commenced at 4:30 p.m. and concluded at 6:25 p.m.
Key Highlights
- RPR & Associates appointed as Secretarial Auditor for five years.
- Appointment subject to shareholder approval at AGM.
- MRR & Associates resigned due to health issues, effective May 22, 2026.
- Board meeting held on May 21, 2026, approved the appointment.
Price Impact
More from AUROPHARMA